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 ABSTRACT 
 The aim of this work was to explore whether epi-
dermal growth factor (EGF) and hepatocyte growth 
factor (HGF) could increase the biological responses of 
a mammary epithelial cell line of bovine origin when 
added simultaneously. We also investigated a possible 
molecular mechanism underlying this cooperation. 
The development of mammary gland requires several 
circulating and locally produced hormones. Hepato-
cyte growth factor and its tyrosine kinase receptor, 
mesenchymal-epithelial transition factor (MET), are 
expressed and temporally regulated during mammary 
development and differentiation. Epidermal growth fac-
tor receptor and its ligands have also been implicated in 
the growth and morphogenesis of the mammary epithe-
lium. Both EGF and HGF seem to exert a morphogenic 
program in this tissue; therefore, we hypothesized that 
these cytokines could act cooperatively in bovine mam-
mary epithelial cells. We have already shown that the 
bovine BME-UV cell line, a nontumorigenic mammary 
epithelial line, expresses both MET and EGF receptor. 
Simultaneous treatment with HGF and EGF elicited 
an increase in proliferation, dispersion, degradation of 
extracellular matrix, and motility. Following EGF treat-
ment, BME-UV mammary cells exhibited an increase in 
MET expression at both the mRNA and protein levels. 
Long-term treatment of BME-UV cells with HGF and 
EGF together increased the level of activation of the 
extracellular signal-regulated kinase 1/2 and protein 
kinase B signaling pathways when compared with HGF 
or EGF alone. These data outline a possible coopera-
tive role of the EGF and HGF pathways and indicate 
that cross-talk between their respective receptors may 
modulate mammary gland development in the cow. 
 Key words:   epidermal growth factor ,  mesenchymal-
epithelial transition factor (MET) ,  bovine mammary 
cell ,  cooperation 
 INTRODUCTION 
 The development of the mammary gland is a highly 
complex and finely tuned mechanism mediated by 
multiple cytokines both remotely and locally produced. 
Endocrine hormones, such as estrogens and growth 
hormone, have a direct stimulatory effect on mammary 
epithelial cells and the ability to induce the release of 
locally produced cytokines. These factors, released by 
the epithelial and mesenchymal compartments of the 
gland, activate mesenchymal-epithelial interactions 
that are essential for the correct development of this 
organ (Sternlicht et al., 2006; Connor et al., 2007). 
Many locally produced signals and their receptors have 
been studied. Among these, 2 well-described tyrosine 
kinase receptors, the epidermal growth factor recep-
tor (EGFR; Stern, 2003) and mesenchymal-epithelial 
transition factor (MET; Bottaro et al., 1991), play an 
important role in the morphogenesis of the mammary 
gland. 
 Epidermal growth factor receptor activates multiple 
intracellular pathways that are often associated with 
cell proliferation and survival. When one of the various 
epidermal growth factor (EGF)-related ligands activate 
this receptor, it dimerizes with another EGFR mono-
mer or 1 of 3 other related receptors—ErbB2, ErbB3, 
or ErbB4. Several EGFR ligands can promote murine 
mammary development if given exogenously (Troyer 
and Lee, 2001). 
 Hepatocyte growth factor (HGF) was originally 
described as a mitogenic factor for hepatocytes dur-
ing liver regeneration, but HGF has a variety of ad-
ditional biological activities including motogenesis and 
morphogenesis in cells that express its receptor, MET 
(Birchmeier et al., 2003). In culture, many epithelial 
cell lines respond to HGF treatment by increased motil-
ity and dispersion (an event known as scatter), hence 
this cytokine was also named “scatter factor.” In col-
lagen matrix, HGF induces the formation of branched 
tubules from epithelial cells derived from the mammary 
gland, the kidney, and other organs. Hepatocyte growth 
factor and MET are expressed and temporally regu-
lated during mammary development and differentiation 
(Yang et al., 1995; Soriano et al., 1998). In this context, 
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mammary fibroblasts produce HGF that is mitogenic, 
morphogenic, and motogenic for both human and 
mouse mammary epithelial cells (Brinkmann et al., 
1995; Soriano et al., 1995).
We and others have recently demonstrated that MET 
is expressed in the bovine mammary gland and bovine 
mammary epithelial cells (Yamaji et al., 2006; Ac-
cornero et al., 2007a). We also showed that activation 
of MET by HGF induced activation of the extracel-
lular signal-regulated kinase 1/2 (ERK1/2) and the 
protein kinase B (AKT) pathways and elicited numer-
ous biological events such as proliferation, scatter, and 
invasion (Accornero et al., 2007b). Similarly, we showed 
that BME-UV cells also express EGFR and that its 
stimulation with EGF activated ERK1/2 and AKT 
but had minimal effects on proliferation, scatter, and 
invasion.
Many studies have demonstrated multiple mechanisms 
of collaboration between EGFR and MET. Primary 
attention has been placed on this interaction in cell 
lines derived from tumors (Ramos-Nino et al., 2003), 
whereas limited data are available on cells obtained 
from nontumorigenic tissues (Moriuchi et al., 2001) 
and, to our knowledge, no studies have demonstrated 
collaborative events between EGF and HGF in normal 
bovine mammary epithelial cells.
Because MET and EGFR are simultaneously ex-
pressed and play an important role during mammary 
development, we investigated whether there was a 
cooperative effect between these receptors in cultured 
bovine mammary epithelial cells.
MATERIALS AND METHODS
Materials, Cells, and Antibodies
All reagents, unless specified, were from Sigma-
Aldrich (St. Louis, MO), as was the protease inhibi-
tor cocktail; recombinant human HGF and EGF were 
from Immunotools (Friesoythe, Germany); NucleoSpin 
RNA II was from Macherey–Nagel (Duren, Germany); 
Bio-Rad iScript cDNA kit, iQ SYBR Green Supermix, 
and DC Protein Assay were from Bio-Rad Laborato-
ries (Hercules, CA); Hybond-ECL nitrocellulose mem-
brane and Hyperfilm ECL were from GE Healthcare 
Bio-Sciences (Piscataway, NJ); Super Signal West 
Pico Chemiluminescent Substrate was from Pierce 
(Rockford, IL); Transwell polycarbonate membranes 
were from Corning-Costar (Lowell, MA); Matrigel 
Basement Membrane Matrix was from BD Biosciences 
(Bedford, MA); the programmable real-time thermal 
cycler (Model Mini-Opticon) was from MJ Research 
Inc. (Watertown, MA); the Leica AF6000 LX inverted 
microscope, the DFC350FX digital camera, and the 
Leica LAS AF software were from Leica Microsystems 
(Wetzlar, Germany); and the CO2 microscope cage in-
cubator was from Okolab (Naples, Italy).
The BME-UV bovine mammary epithelial cell line 
was kindly provided by I. Politis (Agricultural Univer-
sity of Athens, Athens, Greece). The BME-UV cells 
were established from bovine primary epithelial cells 
and express functional markers such as microvilli and 
desmosomes and biochemical markers of mammary 
epithelial cells such as a repertoire of cytokeratins (Za-
vizion et al., 1996). The BME-UV cells were grown 
in Dulbecco’s modified Eagle’s medium high glucose 
(DMEM), supplemented with 10% fetal bovine serum 
(Euroclone, Pero, Italy) at 37°C in a 5% CO2-water-sat-
urated atmosphere. Cells were routinely passaged every 
2 to 3 d by washing with PBS followed by trypsini-
zation. The proliferation, scatter, and invasion assays 
were performed by adding the indicated cytokines to the 
growth medium (DMEM + fetal bovine serum) because 
in the absence of serum, cells progressively lost viability 
and did not respond to these stimuli. For Western blots 
and real-time PCR, cells were serum-starved for 24 h 
in DMEM with no serum in the presence of 0.2% BSA, 
and then the indicated cytokines were added for the 
specified times. In the experiments performed to evalu-
ate MET and EGFR expression, serum starvation was 
necessary to suppress the transcriptional effects of all 
growth factors present in serum. To analyze the effects 
of EGF and HGF on signal transduction serum starva-
tion was required to lower the basal rate of phosphory-
lation of ERK1/2 and AKT otherwise elicited by the 
variety of growth factors present in the serum.
The specific reactivity of anti-MET and anti-EGFR 
antibodies has been previously demonstrated (Ac-
cornero et al., 2007b). Anti-MET mouse monoclonal 
antibody was from Zymed (South San Francisco, CA); 
anti-EGFR rabbit polyclonal antibody was from Santa 
Cruz Biotechnology (Santa Cruz, CA); anti-α-tubulin 
and anti-phospho-ERK 1/2 mouse monoclonal anti-
bodies were from Sigma-Aldrich (St. Louis, MO); anti-
phospho-AKT (ser-473) mouse monoclonal was from 
Upstate (Temecula, CA), and anti-ERK 1/2 rabbit 
polyclonal and anti-AKT rabbit polyclonal antibodies 
were from Cell Signaling Technologies (Danvers, MA).
Cell Proliferation Assay
The BME-UV cells were seeded in 6-well plates at a 
density of 2 × 105 cells per well and allowed to grow. 
After 24 h, the medium was replaced with fresh medium 
with serum containing the indicated cytokines. After 36 
h, cells were detached by trypsinization and counted on 
Burker chambers. Nonviable, Trypan blue-positive cells 
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were not considered. Cell numbers were expressed as a 
percentage of the untreated (control) well’s count.
Scatter Assay
The BME-UV cells were seeded in 6-well plates at 
a density of 3 × 104 cells/well and cultured until they 
formed tightly packed colonies (about 48 h). The me-
dium was replaced with medium containing serum and 
the indicated cytokines and cells were photographed 
using a Leica AF6000 LX inverted microscope equipped 
with a fully automated stage controlled by Leica LAS 
AF software, a Leica DFC350FX digital camera, and a 
CO2 incubator. Images were taken every 3 min for 10 h 
and then exported as AVI videos at 20 frames per sec-
ond. Text was added to the video using the free video 
editor software Wax 2.0 (http://www.debugmode.com/
wax/).
In Vitro Invasion Assay
Invasiveness was examined by using the membrane 
invasion culture system (Transwell polycarbonate mem-
branes; 6.5 mm diameter, 8-μm pore size). The BME-
UV cells were trypsinized and 3 × 104 cells in 200 μL 
of medium with serum were seeded onto the upper well 
of Transwells previously coated with 25 μg of Matrigel 
basement membrane matrix. The lower well was filled 
with 800 μL of complete medium and the indicated cy-
tokines were added. After 48 h, the noninvasive cells on 
the upper surface of the membrane were removed with a 
cotton swab. Cells that solubilized the Matrigel, passed 
through the 8-μm pores of the Transwell, and attached 
to the lower surface of the membrane were fixed with 
11% glutaraldehyde, stained with crystal violet, and 
photographed. For quantification, the Transwell mem-
branes were detached and solubilized in 10% acetic acid 
water solution and the intensity of the colored solution 
was quantified by spectrophotometric analysis at 595 
nm. Intensities were expressed as a percentage of the 
untreated (control) Transwell’s intensity.
Western Blot Analysis
Cells were plated in 6-well plate and cultured until 
they reached 50% confluence. Cells were incubated for 
24 h in medium without serum containing 0.2% BSA 
and, following another change of medium, the indicated 
cytokines were added and incubated for 16 h. Cells 
were washed with ice-cold PBS, lysed, and scraped 
in lysis buffer [20 mmol of Tris/L, pH 7.5; 150 mmol 
of NaCl/L; 1 mmol of EDTA/L; 1 mmol of ethylene 
glycol tetraacetic acid (EGTA)/L; 1% Triton X-100; 
1 mmol of h-glycerolphosphate/L] with 1% protease 
inhibitor cocktail (Sigma-Aldrich) and 1 mmol of 
sodium-orthovanadate/L. Protein lysates were cleared 
of cellular debris by centrifugation at 4°C at 12,000 × 
g for 10 min, quantified using the DC Protein Assay, 
resolved in 10% SDS-PAGE gels, and transferred to 
Hybond-C Extra nitrocellulose membranes. After the 
transfer of proteins, the membrane was blocked at room 
temperature for 2 h with Tris-buffered saline (TBS, 
10 mM Tris and 150 mM NaCl, pH 7.4) containing 
10% BSA and then incubated overnight at 4°C with 
the appropriate primary antibodies. The membranes 
were washed 6 times for 5 min each in TBS-Tween 
and then incubated for 1 h at room temperature with 
horseradish peroxidase conjugated secondary antibod-
ies. The membranes were again washed several times 
in TBS-Tween and incubated with Super Signal West 
Pico enhanced chemiluminescence peroxidase substrate 
for 5 min at room temperature. The proteins were visu-
alized by exposing the membrane to a Hyperfilm ECL 
autoradiography film.
Preparation of mRNA and Real-Time PCR
Cells were plated in 6-well plates and cultured until 
they reached 50% confluence. Cells were serum-starved 
for 24 h in medium without serum containing 0.2% BSA 
and then, following another change of medium, the in-
dicated cytokines were added and incubated for 16 h. 
Total RNA was extracted with a NucleoSpin RNA II 
kit following the manufacturer’s recommended protocol. 
One microgram of total RNA was reverse transcribed 
with an iScript cDNA kit following the manufacturer’s 
instructions. Real-time PCR was used to measure the 
quantity of MET relative to the quantity of hypoxan-
thine phosphoribosyl-transferase 1(HPRT-1) mRNA. 
The HPRT-1 gene was used as a normalization gene to 
correct for RNA concentration and reverse transcription 
efficiency. Diluted cDNA (1:5 and 1:50) were used for 
real-time PCR amplification using iQ SYBR Green Su-
permix. Primers for bovine MET were: forward 5′-CGC 
TAT GAT GCA AGA GTA CAC A-3′, reverse 5′-TTA 
GGA AAC TGG TCT TCT GGA-3′ (efficiency 1.79); 
primers for HPRT-1 were: forward 5′-TGA CAC TGG 
CAA AAC AAT GCA-3′, reverse 5′-GGT CCT TTT 
CAC CAG CAA GCT-3′ (efficiency 1.87). Real-time 
PCR parameters were: cycle 1, 95°C for 3 min; cycle 2, 
95°C for 60 s, 60°C for 30 s for 40 cycles. The Δ(ΔCT) 
method was used to analyze the data as described by 
Livak and Schmittgen, (2001).
Statistical Analysis
Each experiment was repeated 3 times independently 
and in each experiment each treatment was performed 
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with 2 to 3 replicates. Experimental data are presented 
as mean ± standard deviation. Statistical differences 
between treatments were calculated with one-way 
ANOVA using the Statgraphics package (STSC Inc., 
Rockville, MD). When significant differences were 
found, means were compared by Scheffe’s F test.
RESULTS
Simultaneous Addition of HGF and EGF  
Increases Proliferation of BME-UV Bovine  
Mammary Epithelial Cells
We previously reported that BME-UV bovine mam-
mary cells express both EGFR and MET and that 
these cells respond to HGF or, to a lesser extent, EGF 
addition by increased proliferation (Accornero et al., 
2007b). Thus, we verified that simultaneous addition 
of HGF + EGF promoted proliferation in this cell line 
beyond that observed with HGF or EGF alone. Cells 
were plated and cultured for 36 h in standard medium 
without (control), with HGF, with EGF, or with HGF 
+ EGF (10 ng/mL each). To evaluate differences be-
tween the treatments, cells were trypsinized, stained 
with Trypan blue (to exclude nonviable cells) and 
counted. Quantities were expressed as a percentage of 
the control group’s count. The HGF + EGF treatment 
had the strongest potential to induce cell proliferation 
(245%, P < 0.05) compared with EGF (197%) or HGF 
(205%; Figure 1).
Enhanced Motility and Dispersion (Scatter) of  
BME-UV Cells after Stimulation with HGF and EGF
We reported previously that BME-UV cells exhibited 
a scatter response to HGF but not EGF treatment. 
Thus, we tested whether HGF and EGF could syner-
gize to evoke scatter in BME-UV cells. To determine a 
possible collaboration between EGF and HGF in this 
assay, we reduced the amount of HGF added to the me-
dium to 0.15 ng of HGF/mL (Figure 2; HGF), because 
of the fact that HGF alone, used at high concentrations 
(10 ng of HGF/mL), induced complete dissociation of 
cells (Accornero et al., 2007b). At 0.15 ng of HGF/
mL, HGF did not evoke scatter, and cells were indis-
tinguishable from untreated control (Figure 2, control). 
Cells treated with EGF (10 ng of EGF/mL) also never 
completely dissociated [Figure 2, EGF; and Accornero 
et al., (2007b)]. Interestingly, HGF + EGF promoted 
cell detachment and motility to a much higher degree 
(Figure 2, HGF + EGF; and supplementary video, 
available online: http://jds.fass.org/content/vol92/is-
sue8/).
EGF and HGF Simultaneous Addition  
Promotes Increased Invasion
We previously showed that HGF promoted invasion 
in BME-UV cells, whereas EGF had a low invasive po-
tential. We therefore tested whether HGF (10 ng/mL) 
and EGF (10 ng/mL) could synergize in this assay: 
untreated and EGF-treated cells did not invade (Figure 
3A, control and EGF), whereas HGF induced cells to 
dissolve the matrix and to pass through the pores of the 
Transwells. The BME-UV cells stimulated concurrently 
with HGF and EGF were significantly more invasive 
(Figure 3A, HGF + EGF). Quantification of cells that 
passed through the Transwells confirmed that HGF + 
EGF had a synergistic effect on invasion (Figure 3B; P 
< 0.05).
EGF Increases Expression of MET  
Protein and mRNA
We analyzed possible variations in the expression 
levels of MET and EGFR in BME-UV cells after in-
duction with HGF or EGF. For this purpose, cells were 
serum-starved for 24 h and then either left unstimulated 
(control) or treated for 16 h with HGF (10 ng/mL), 
EGF (10 ng/mL) and HGF plus EGF. Cells were lysed 
and 20 μg of total protein cell extracts were separated 
by SDS-PAGE and analyzed by immunoblotting for the 
expression of MET and EGFR. Tubulin immunoblot-
ting was used to confirm that equal amounts of protein 
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Figure 1. Effect of epidermal growth factor (EGF) and hepatocyte 
growth factor (HGF) treatment on BME-UV mammary cell prolifera-
tion. The BME-UV cells were cultivated for 36 h with no cytokines 
(control), 10 ng of HGF/mL, 10 ng of EGF/mL, or 10 ng of EGF/mL 
plus 10 ng of HGF/mL and then counted. Each bar shows quantifica-
tion, in percentage relative to the untreated control. Graph bars repre-
sent the mean ± standard deviation of 3 experiments with 2 replicates 
per each treatment. *P < 0.05 vs. control; **P < 0.05 vs. HGF.
had been correctly loaded. In EGF-treated cells, we 
observed an increase in the expression of MET when 
compared with control or HGF-treated cells (Figure 
4A). Treatment with EGF also dramatically lowered 
the expression of its own receptor, a well-described 
mechanism that involves internalization and degra-
dation (Sorkin and von Zastrow, 2002). Densitomet-
ric analysis of Western blots confirmed an effect on 
MET and EGFR expression in EGF and HGF + EGF 
treated cells (Figure 4B; P < 0.05). We then analyzed 
whether the increased expression level of MET after 
EGFR activation could also be observed at the mRNA 
level. Cells were serum-starved for 24 h and stimulated 
with HGF, EGF, or HGF plus EGF for 16 h. Total 
RNA was extracted and real-time PCR was used to 
measure the relative levels of MET mRNA expression 
after normalization with HPRT mRNA (Figure 4C). 
In agreement with the data obtained by Western blot 
analysis, we observed a 2- to 5-fold increase in MET 
mRNA level (mean = 2.96 times; P < 0.05) in EGF 
treated samples compared with the level of untreated 
(control) cells. Treatment with HGF only slightly 
stimulated MET expression (1.2- to 1.4-fold vs. con-
trol, mean = 1.34).
Prolonged Treatment of BME-UV Cells with HGF and 
EGF Enhances the Activation of ERK1/2 and AKT
We have previously demonstrated that both HGF 
and EGF activate the ERK 1/2 and the AKT pathways 
in BME-UV cells and that deactivation via dephospho-
rylation of both effectors occurs rapidly (Accornero et 
al., 2007b). The increase in proliferation (36 h), scatter 
(10 h) and invasion (48 h) mediated by EGF plus HGF 
is the result of chronic activation of multiple intracellu-
lar signaling pathways. Thus, we verified whether HGF 
and EGF, when added simultaneously, could enhance 
the activation of the ERK1/2 and AKT pathways even 
after a long incubation time. To lower the basal rate of 
phosphorylation of ERK1/2 and AKT cells were serum-
starved for 24 h and then left unstimulated (control) or 
stimulated with HGF (10 ng/mL), EGF (10 ng/mL), 
or HGF + EGF (H + E) for 1, 4, or 8 h. Twenty mi-
crograms of total cell protein extracts were analyzed by 
immunoblotting with specific ERK1/2 and AKT anti-
phospho antibodies. Total ERK1/2 and AKT were used 
as loading controls. The rate of activation of ERK1/2 
and AKT in untreated cells was low but increased after 
HGF treatment. Addition of EGF provided a further 
increase of ERK1/2, but not AKT phosphorylation 
compared with HGF. Interestingly, the HGF + EGF 
treatment enhanced the activation of both ERK1/2 
and AKT at all time intervals (Figure 5).
DISCUSSION
In this study, we determined that MET and EGFR 
collaborate in many biological responses of BME-UV 
bovine mammary cells. The mammary gland is an 
organ in which a large number of remodeling events 
follow one another during the development and the 
reproductive cycle of the animal. After puberty and 
during pregnancy, proliferation and morphogenesis of 
the mammary epithelium results in the development of 
an extended network of ducts and alveoli. Branching 
morphogenesis and lobulo-alveolar differentiation of the 
mammary gland are regulated by a complex interplay of 
systemic hormonal signals and local factors (Imagawa 
et al., 2002). In these processes, mesenchymal-epithelial 
as well as epithelial-mesenchymal cell interactions play 
an important role. Paracrine factors are produced from 
the epithelial compartment of the gland (luminal and 
myoepithelial cells) and from the surrounding mes-
enchyma, mainly adipocytes and fibroblasts. Among 
these factors, EGF and HGF play an important role for 
the correct development of the gland (Yang et al., 1995; 
Troyer and Lee, 2001).
Epidermal growth factor acts by activating its re-
ceptor EGFR and it is reported to have an important 
role both in the epithelial and luminal compartments 
(Luetteke et al., 1999). In particular, one of the EGFR 
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Figure 2. Effect of hepatocyte growth factor (HGF), epidermal 
growth factor (EGF), and HGF + EGF treatments on bovine mamma-
ry cell scatter. The BME-UV cells were seeded at low density and cul-
tured until they formed tightly packed clusters. Subsequently, 0.15 ng 
of HGF/mL, 10 ng of EGF/mL, or 10 ng of EGF/mL plus 0.15 ng of 
HGF/mL were added to the culture medium. After 10 h, cells were 
photographed on a Leica DMI6000B inverted microscope at 50× mag-
nification. The scatter assay was repeated 3 times with similar results. 
Microphotographs were acquired every 3 min for 10 h and assembled 
to a 20-frame per second video. Supplementary video available online: 
http://jds.fass.org/content/vol92/issue8/.
multiple ligands, amphiregulin, which is secreted by 
mammary epithelial cells that express estrogen recep-
tor α, plays a fundamental role to promote the morpho-
genesis of the gland by activating EGFR in the stromal 
compartment. Interestingly, EGFR is also expressed 
in murine and bovine mammary epithelial cells, and 
therefore there might be a signaling function for this 
receptor in the epithelial compartment as well (Ciarloni 
et al., 2007; Connor et al., 2007).
Hepatocyte growth factor, on the other hand, is 
secreted from mesenchymal/stromal cells and acts on 
adjacent epithelial cells by activating the MET recep-
tor. Hepatocyte growth factor has been described as a 
possible mediator of the morphogenic program in many 
cell lines of different origin including mammary cells 
(Soriano et al., 1995).
Recent evidence has outlined mechanisms of interac-
tion between MET and EGFR that ultimately drive 
some biological and pathological processes including 
wound healing and cancer (Yamamoto et al., 2006; Xu 
and Yu, 2007). We have previously shown that BME-UV 
mammary cells express MET and EGFR (Accornero 
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Figure 3. Effect of hepatocyte growth factor (HGF), epidermal 
growth factor (EGF), and HGF + EGF treatments on BME-UV cell 
invasion. Cells were seeded on Matrigel-coated Transwells and then 
either left untreated (control) or treated with 10 ng of HGF/mL, 10 ng 
of EGF/mL, or 10 ng of EGF/mL plus 10 ng of HGF/mL. A) Pictures 
of Transwells; B) spectrophotometric quantification of the Transwells 
in panel A. Untreated Transwells were used as control. Increase in cell 
invasion is expressed as fold increase in treated cells compared with 
control, which was assigned a value of 1. Pictures are representative 
of 3 different experiments with 2 replicates each; bar graphs are the 
means ± standard deviation of the same experiments. *P < 0.05 vs. 
control; **P < 0.05 vs. HGF.
Figure 4. Effect of hepatocyte growth factor (HGF), epidermal 
growth factor (EGF), and HGF + EGF treatments on mesenchymal-
epithelial transition factor (MET; the HGF receptor) and EGF recep-
tor (EGFR) protein levels and on MET mRNA expression. The BME-
UV cells were serum-starved for 24 h and then left untreated (control) 
or treated for 16 h with 10 ng of HGF/mL, 10 ng of EGF/mL, or 
10 ng of HGF/mL plus 10 ng of EGF/mL before being lysed for total 
protein or mRNA extraction. A) MET (140 kDa), EGFR (170 kDa), 
and tubulin (Tub; 50 kDa) proteins were detected with specific anti-
bodies; tubulin was used as a total protein loading control. Pictures 
are representative of 3 different Western blot analyses. B) The relative 
intensity of MET or EGFR was normalized to total value of tubulin 
determined by densitometric analysis. Each bar shows quantification 
as a percentage relative to the untreated control (control). *P < 0.05 
vs. control. C) The MET mRNA level was assessed through quanti-
tative real-time PCR using specific primers that anneal on different 
exons. Data were normalized to HPRT expression and comparisons 
among different samples were made using the cycle threshold (ΔΔCT) 
method; each bar shows quantification as a percentage relative to the 
untreated control (control). Graph bars represent the mean ± stan-
dard deviation of 3 different experiments with 3 replicates per each 
treatment. *P < 0.05 vs. control.
et al., 2007b) and that both receptors, if stimulated 
by their respective ligands, activate the ERK1/2 and 
the AKT pathways. We also showed that HGF, but 
not EGF, induced multiple morphogenic responses like 
scatter and invasion in this cell line. Because mammary 
epithelial cells are exposed to both EGF and HGF dur-
ing the development of the gland, we postulated that 
these 2 growth factors may exert cooperative effects on 
the phenotypic modulation of mammary cells.
Many mammary epithelial cell lines have been shown 
to respond with proliferation when treated with differ-
ent growth factors, including HGF or EGF. We first 
observed that BME-UV cells treated with HGF and 
EGF together responded with increased proliferation 
compared with the treatment with each cytokine alone. 
Cooperative mitogenic effects of HGF plus either EGF 
or TGF-α have also been reported in cultured rat hepa-
tocytes, implying that cooperativity may exist between 
these growth factor/receptor pathways (Jo et al., 2000; 
Moriuchi et al., 2001).
Scatter is a phenomenon documented in many cell 
types, in which cohesive cell colonies spread out, 
separate into individual cells and acquire a fibroblastic 
migratory phenotype. We already demonstrated that 
HGF, but not EGF, had a strong scatter-inducing abil-
ity on BME-UV cells. To test if HGF and EGF col-
laborated in this assay we lowered HGF concentrations 
to preclude mammary cells to scatter by the mean of 
this cytokine alone. The data available on the local ac-
tive concentrations of all paracrine factors that mediate 
morphogenesis in the mammary gland are still poor. 
In fact, the biological availability of many cytokines is 
modulated, in-vivo, by multiple factors including, for 
example, the presence of enzymes required for the local 
activation of these cytokines (TACE/ADAM17 for EGF 
ligands and urokinase plasminogen activator or tissue 
plasminogen activator for HGF) or the presence of the 
basement membrane and multiple layers of cells that 
may modulate the diffusion of these hormones (Birch-
meier and Gherardi, 1998; Harris et al., 2003). Under 
our experimental conditions (reduced HGF concentra-
tion) we showed that EGF collaborates with HGF to 
induce scatter in BME-UV cells. Because scatter is a 
necessary event that occurs before several morphogenic 
processes that are also active during mammary gland 
development, we speculate that HGF and EGF might 
collaborate to evoke scatter in this context.
In this work, we also showed that invasion is increased 
in the presence of EGF and HGF together. During em-
bryogenesis, in a physiological context, invasive growth 
is involved in complex developmental events including 
morphogenesis of epithelia, angiogenesis, nerve sprout-
ing, and myoblast migration (Birchmeier and Gherardi, 
1998). This feature is of great importance in the develop-
ing mammary gland. In this context, cells that colonize 
the gland and create the new tubular structures of this 
organ, degrade the surrounding extracellular matrix, 
proliferate and move to create new tissue.
The BME-UV cell line stimulated with HGF re-
sponded with an enormous increase in the ability to 
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Figure 5. Effect of hepatocyte growth factor (HGF) and epidermal growth factor (EGF) simultaneous treatment on extracellular signal-
regulated kinase (ERK) and protein kinase B signal (AKT) signal transduction pathways in BME-UV cells. Cells were serum-starved for 24 h 
and then either left untreated (control) or treated for 1 h, 4 h, or 8 h with 10 ng of HGF/mL, 10 ng of EGF/mL, or 10 ng of HGF/mL plus 
10 ng of EGF/mL. Subsequently cells were lysed and protein lysates were immunoblotted. The phosphorylated (p) forms of ERK1/2 (42 and 44 
kDa) and AKT (60 kDa) proteins were detected with specific antibodies. The same membranes were then stripped and reprobed against total 
ERK1/2 and AKT. Pictures shown are representative of 3 different Western blot analyses.
degrade the extracellular matrix (matrigel) and move 
through Transwell pores. Interestingly, under the same 
conditions EGF had a very mild capacity to induce 
invasion whereas EGF and HGF when added together 
induced invasion synergistically. Other authors have 
demonstrated a similar collaborative role for these 
growth factors in ovarian cancer cells (Zhou et al., 
2007).
To uncover a possible molecular mechanism of col-
laboration between EGFR and MET, we decided to 
examine if EGF or HGF could influence the other 
receptor’s signaling pathway. Multiple mechanisms of 
cooperation between MET and EGFR have been de-
scribed, among which are trans-phosphorylation and 
ligand/receptor upregulation (Ramos-Nino et al., 2003; 
Spix et al., 2007). We did not detect any trans-phos-
phorylation event between EGFR and MET in BME-
UV cells treated with EGF or HGF (data not shown). 
We observed an increase in MET protein and mRNA 
in EGF treated cells while EGFR expression, strongly 
down-modulated by EGF addition, was not altered by 
HGF. Result supports the concept that MET upregula-
tion in response to EGF is a one-way signaling mode of 
this cell line.
Activation of MET and EGFR by ligation of active 
HGF or EGF allows the recruitment of numerous sig-
naling mediators such as phosphoinositide 3-kinase and 
Src tyrosine kinase, as well as several adaptor proteins 
such as Grb2 (which activates the ERK pathway), 
Gab1, Shc, and c-Cbl. We previously showed that HGF 
or EGF addition to BME-UV cells induced activa-
tion of the ERK1/2 and AKT pathways (Accornero 
et al., 2007b). In this context, EGFR may contribute 
to MET signaling by amplification of common down-
stream pathways, thereby increasing the potential of 
MET to induce long-term morphogenic-promoting 
effects including proliferation, scatter, and invasion. 
Thus, we verified possible consequences of the simul-
taneous treatment of BME-UV cells on the activation 
persistency of the ERK1/2 and AKT pathways. Cells 
stimulated concurrently with HGF and EGF for 1, 4, 
and 8 h showed an increase in the phosphorylation of 
these effectors compared with HGF or EGF alone. This 
type of cooperative event has not been described in 
bovine mammary cells, but has been already demon-
strated in another context. During liver regeneration, 
EGFR and MET were shown to collaborate through 
an additive effect on growth by concurrent activation 
of the Ras/ERK pathway in rat hepatocytes (Moriuchi 
et al., 2001).
In summary, in this work we have verified that HGF 
and EGF collaborate in eliciting several biological 
responses of bovine mammary epithelial cells and we 
propose a possible molecular mechanism underlying 
this collaboration. The effects described in this work 
show how HGF and EGF, acting together through their 
respective receptors, MET and EGFR, promoted an 
increase in proliferation, scatter, and invasion. This 
study also provides evidence for a mechanism of com-
munication between the EGFR and MET pathways. 
Finally, we showed that activation of both EGFR and 
MET signaling cascades can result in cooperative ac-
tivation of downstream signaling effectors that may 
enhance biological outcomes. We propose that HGF-
dependent MET signaling may be amplified by concur-
rent activation of the EGFR, which results in increased 
HGF-induced proliferation, scatter, and invasion in 
mammary bovine cells. Together, these data suggest 
that HGF and EGF might be important regulators of 
morphogenesis and development in bovine mammary 
gland.
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